Company Overview of Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapies to treat liver disease. It offers MSDC-0602K, a second-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis. Cirius Therapeutics, Inc. was formerly known as Octeta Therapeutics, LLC. The company was incorporated in 2015 and is headquartered in Kalamazoo, Michigan.
161 East Michigan Avenue
Kalamazoo, MI 49007
Founded in 2015
Key Executives for Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
March 24, 2017
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
To contact Cirius Therapeutics, Inc., please visit www.ciriustx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.